Physicians' Awareness of ECG Abnormalities Linked to Acute Ischemic Chest Pain
November 14, 2025 updated by: Mohamed Ezzat Nasreddin, Tanta University
Physicians' Awareness of ECG Abnormalities Linked to Acute Ischemic Chest Pain; A Survey Study
This study aims to investigate physicians' awareness regarding patients presenting with potential acute ischemic chest pain.
It focuses on various electrocardiogram (ECG) patterns requiring prompt catheter lab activation for reperfusion therapy alongside other ECG mimics that may lead to false catheter lab activations.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Chest pain is the second most common complaint in adult emergency department (ED) patients in the United States. Most visits result in a diagnosis of noncardiac chest pain and approximately half in nonspecific chest pain. Roughly 6% are ultimately diagnosed with a life-threatening condition, which is overwhelmingly (>90%) acute coronary syndrome (ACS).
The term acute coronary syndrome (ACS) is applied to patients in whom there is a suspicion or confirmation of acute myocardial ischemia or infarction. ST-elevation myocardial infarction (STEMI), Non-ST-elevation MI (NSTEMI), and unstable angina are the three traditional types of ACS.
Study Type
Observational
Enrollment (Actual)
640
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
El-Gharbia
-
Tanta, El-Gharbia, Egypt, 31527
- Tanta University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
A consecutive sample of 500 physicians who treat patients with possible acute ischemic chest pain will be the subject of this cross-sectional survey study.
These doctors will include emergency physicians, cardiologists, internal medicine/acute medicine specialists, general practice or family physicians, anesthesiologists, and intensive care physicians of both sexes, with varying degrees of experience and post-graduate clinical training, from all over the world.
Description
Inclusion Criteria:
- Age from 25 to 65 years.
- Both sexes.
- Physicians who treat patients with possible acute chest pain.
Exclusion Criteria:
- Participants who failed to complete the survey questions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1
All physicians are subjected to 10 ECGs Surves
|
All participants will consent to submit an anonymous Google Form-based questionnaire.
The designed questionnaire includes introductory personal, academic, and work experience data about the physicians as gender, age, current specialty, workplace, highest achieved medical-academic or training degree, and number of years of postgraduate clinical work experience.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physicians' Awareness
Time Frame: At time of online survey (Up to 2 months)
|
Physicians' awareness is measured by a numerical score of 0 to 10, depending on the electrocardiogram (ECG) pattern survey.
0 means (least recognition of ECG pattern) and 10 (high recognition of ECG pattern)
|
At time of online survey (Up to 2 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 20, 2025
Primary Completion (Actual)
August 29, 2025
Study Completion (Actual)
September 30, 2025
Study Registration Dates
First Submitted
February 13, 2025
First Submitted That Met QC Criteria
February 19, 2025
First Posted (Actual)
February 20, 2025
Study Record Updates
Last Update Posted (Actual)
November 18, 2025
Last Update Submitted That Met QC Criteria
November 14, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 36264PR955/11/24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
IPD Sharing Time Frame
After the end of study for one year.
IPD Sharing Access Criteria
The data will be available upon a reasonable request from the corresponding author.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.